[VEILLE] The impact of acceleration factors in 4D flow MRI

ANSM has published its application guide, which supplements and adapts certain points in the appendix to the January 15, 2020 decision setting out the quality control procedures for digital mammography facilities, in order to facilitate its implementation.
The decision of January 15, 2020 applies from January 15, 2021.

Interest of the study

In the event of a tube change, the decision provides for the following tests to be carried out as part of the IQC:

These tests should also be carried out when a software version is changed, modifying the projection dose.

Interest of the study

From now on, a new control is to be carried out internally: (Homogeneity of reconstructed tomosynthesis image and SNR monitoring).

The decision allows the use of a 45 mm thick PMMA block if the dedicated mammography calibration block supplied by the manufacturer is to be used at tube level. A set of PMMA sheets with a total thickness of 45 mm can also be used.

It should also be noted that the dimensions of the PMMA block or 45 mm thick sheet assembly are 240 mm x 320 mm. In other words, if the manufacturer’s calibration phantom is to be used at Potter level, it must be used for IQC.

The decision mentions the software needed to check receiver homogeneity, the homogeneity of the reconstructed tomosynthesis image and SNR monitoring, and to check for uncorrected defective elements, as mentioned in point In fact, as part of internal quality control, only the test of reconstructed tomosynthesis image homogeneity and SNR monitoring mentioned in section requires the use of software. In particular, this software can be made available by the manufacturer on the acquisition console of the mammograph or plate reader.

If this is not the case, you can use the Flatfield software proposed by the LRCB and available on the ANSM. If the software is not available on site, the EQC cannot issue a non-conformity on this point, pending installation of the software.

Our experts are at your disposal, so don’t hesitate to contact them:
03 69 09 21 30

Share this article

Share on Facebook
Share on Linkdin

Let's talk together!

Are you a health care professional?

Stay informed with our free relationship program for outreach professionals.

Want to become a partner?

Distribution, R&D, clinical tests…
Contact us!